Clinical Trial Update: Perillyl Alcohol in Preventing Recurrent Breast Cancer in Women Who Have Been Treated With Surgery With or Without Adjuvant Therapy [Phase 1]

View source ↗

Summary

Phase 1 clinical trial evaluating perillyl alcohol to prevent recurrence of breast cancer in women treated with surgery, with or without adjuvant therapy.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• Perillyl Alcohol (perillyl alcohol)

Snippet

Sponsor: The Cleveland Clinic | Conditions: Breast Cancer | Phase 1 | Status: UNKNOWN